A drug treatment that acts as a decoy against SARS-CoV-2 was highly effective at preventing death and lung damage in humanized animal models of severe COVID-19 disease. The study suggests that the drug has the potential to treat COVID-19 patients, including those who are infected with aggressive SARS-CoV-2 variants.
Click here for original story, ‘Decoy’ protein works against multiple SARS-CoV-2 variants, researchers report
Source: ScienceDaily